Physician Views: Which companies excel in diabetes drug marketing and why?

Physician Views: Which companies excel in diabetes drug marketing and why?

Code: FW-20150501 | Published: May-2015 | Pages: - | FirstWord
Price :
$695.00
USD

* Required Fields

$695.00

Details






With both the insulin and non-insulin segments of the diabetes market expected to become more competitive through to the end of this decade (see FirstWord Lists: Blockbuster diabetes drugs 2014 and 2020), FirstWord is once again polling US and EU5-based endocrinologists to ascertain which companies are considered to provide the most comprehensive approach to product detailing in the diabetes market.

The insulin market will be shaped by the recent approval of Sanofis Toujeo in the US and EU markets, with Novo Nordisks basal competitor Tresiba expected to gain long-awaited FDA clearance towards the end of this year. Emergence of generic or biosimilar Lantus - at the hands of Eli Lilly - will further shift the commercial dynamic of this segment.

In the non-insulin market, the SGLT-2 inhibitors continue to make strong ground, with multiple drugs in this class now available, while physicians have very recently suggested to FirstWord that they anticipate further notable expansion for the GLP-1 agonist market, which is led by Novo Nordisks Victoza, but has newer entrants including Eli Lillys Trulicity.

Clinical differentiation across multiple brands within each drug class is limited; a dynamic beneficial to payers who have sought to increase pressure on rebates offered for the US market and one that illustrates the importance of an effective marketing capability in the diabetes market.






Specifically, we are asking endocrinologists



- Which prescription pharmaceutical, diabetes-specialist, provides you with the most comprehensive and satisfactory approach in terms or product detailing/MSL engagement?
- Which individual insulin diabetes products have been most effectively promoted/detailed to you over the past year?
- Which individual non-insulin diabetes products have been most effectively promoted/detailed to you over the past year?
- Which factor best describes why you selected these products?
- What factor would best improve your interaction with diabetes sales representatives?


Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
FirstWord

Our Clients